“ the fact that the number of people in our country with some form of arthritis is expected to rise from 40 million to 60 million over the next 20 years show that pharmaceutical companies that produce drugs for the treatment of arthritis should be very p

“ the fact that the number of people in our country with some form of arthritis is expected to rise from 40 million to 60 million over the next 20 years show that pharmaceutical companies that produce drugs for the treatment of arthritis should be very profitable . Most analysts believe that becton pharmaceuticals, which makes xenon, the best selling drug for arthritis, will be the most profitable pharmaceutical company in ten years. But the patent on xenon expires in 3 years, and other company can produce a cheaper version of the drug. Thus, it is more likely that in ten years the most profitable pharmaceutical company will be the perkins pharmaceutical , maker of the new drug called XYLAN. Which clinical studies show is preferred over xenon by 70 percent of patients suffering from the most extreme cases of arthritis.